Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation.

about

Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation.

Item

http://www.wikidata.org/entity/Q52619257

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation.

@en

Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation.

@nl

type

Item

label

Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation.

@en

Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation.

@nl

prefLabel

Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation.

@en

Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation.

@nl

P1476

Circulating Tumor Cells: Strategies for Capture, Analyses, and Propagation.

@en

P2093

Ashutosh Agarwal

http://www.w3.org/2001/XMLSchema#string

Dorraya El-Ashry

http://www.w3.org/2001/XMLSchema#string

Marija Balic

http://www.w3.org/2001/XMLSchema#string

Richard J Cote

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Isolation of rare circulating tumour cells in cancer patients by microchip technology

The epithelial-mesenchymal transition generates cells with properties of stem cells

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Prospective identification of tumorigenic breast cancer cells

Detection of circulating tumor cells

Epithelial-mesenchymal transitions: insights from development

Emerging technologies for CTC detection based on depletion of normal cells

Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

P304

70-77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PPO.0000000000000310

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29601333

http://www.w3.org/2001/XMLSchema#string

P932

5880323

http://www.w3.org/2001/XMLSchema#string